NSTG - NanoString Technologies, Inc.
After hours:
| Previous close | 5.73 |
| Open | 5.85 |
| Bid | 5.45 x 900 |
| Ask | 5.86 x 1000 |
| Day's range | 5.70 - 5.98 |
| 52-week range | 4.37 - 18.51 |
| Volume | |
| Avg. volume | 930,134 |
| Market cap | 274.063M |
| Beta (5Y monthly) | 1.63 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.26 |
| Earnings date | 02 Aug 2023 - 07 Aug 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 16.43 |
Business WireOwkin Powers a New Era in Oncology Research with MOSAIC – An Unprecedented $50 Million Spatial Atlas of Cancer Cells
PARIS & SEATTLE, June 01, 2023--Owkin, Nanostring (NASDAQ:NSTG), and world-leading cancer research institutions University of Pittsburgh, Gustave Roussy, Lausanne University Hospital, Uniklinikum Erlangen/Friedrich-Alexander-Universität Erlangen-Nürnberg, and Charité - Universitätsmedizin Berlin are launching MOSAIC (Multi Omic Spatial Atlas In Cancer) at the American Society of Clinical Oncology’s annual meeting (booth #4037). MOSAIC is a landmark $50 million project to revolutionize cancer res
PR Newswire10x Genomics Files Two New Lawsuits Requesting Preliminary Injunctions Against NanoString's CosMx Products
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it filed new patent litigation against NanoString Technologies, Inc. (Nasdaq: NSTG) and Vizgen, Inc. in the European Unified Patent Court.
Business WireNanoString to Webcast Presentation from Jefferies Healthcare Conference
SEATTLE, May 31, 2023--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the Jefferies Healthcare Conference, which will be held June 7-9, 2023.
Simply Wall St.NanoString Technologies Independent Director Acquires 313% More Stock \
Investors who take an interest in NanoString Technologies, Inc. ( NASDAQ:NSTG ) should definitely note that the...
Business WireNanoString to Host Conference Call on Monday, May 22, 2023, to Provide Comments on Decision of the Regional Court of Munich
SEATTLE, May 22, 2023--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will host a conference call on Monday, May 22, 2023, at 4:30pm ET to provide an update on the recent Decision of the Regional Court of Munich.
Motley FoolWhy Shares of NanoString Technologies Are Falling Thursday
Shares of NanoString Technologies (NASDAQ: NSTG) were down more than 16% Thursday morning and were down as much as 28.3% earlier in the day after the life sciences company lost a patent ruling in Germany. NanoString makes instruments and services to profile genes and proteins from tissue samples. The biotech company lost a patent court fight to 10x Genomics (NASDAQ: TXG) that forces NanoString to quit selling its CosMx Spatial Molecular Imager instruments and CosMx reagents for RNA detection in Germany.
Business WireNanoString Responds to Decision of the Regional Court of Munich
SEATTLE & MUNICH, May 17, 2023--NanoString Responds to Decision of the Regional Court of Munich.
- PR Newswire
10x Genomics Wins Permanent Injunction Against NanoString's CosMx Products
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has won an injunction in its patent litigation against NanoString Technologies, Inc. (Nasdaq: NSTG) and NanoString Technologies Germany GmbH.
- Simply Wall St.
It's A Story Of Risk Vs Reward With NanoString Technologies, Inc. (NASDAQ:NSTG)
You may think that with a price-to-sales (or "P/S") ratio of 3.1x NanoString Technologies, Inc. ( NASDAQ:NSTG ) is a...
ZacksNanoString Technologies (NSTG) Reports Q1 Loss, Tops Revenue Estimates
NanoString (NSTG) delivered earnings and revenue surprises of -22.22% and 8.89%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Business WireNanoString Technologies Releases Operating Results for First Quarter of 2023
SEATTLE, May 03, 2023--NanoString reports operating results for first quarter of 2023.
- Simply Wall St.
Investors in NanoString Technologies (NASDAQ:NSTG) have unfortunately lost 69% over the last year
NanoString Technologies, Inc. ( NASDAQ:NSTG ) shareholders should be happy to see the share price up 27% in the last...
Business WireNanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023
SEATTLE, April 10, 2023--NanoString to report Q1 2023 operating results on May 3, 2023.
Business WireNanoString Reports Inducement Grants Under Nasdaq Listing Rules
SEATTLE, March 08, 2023--NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 16 new employees.
- Simply Wall St.
NanoString Technologies Full Year 2022 Earnings: EPS Misses Expectations
NanoString Technologies ( NASDAQ:NSTG ) Full Year 2022 Results Key Financial Results Revenue: US$127.3m (down 12% from...
Business WireNanoString to Webcast Panel on AI-Based Genomics and Drug Discovery from the 43rd Annual Cowen Health Care Conference
SEATTLE, March 01, 2023--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to participate in a panel discussion, "AI-Driven Disruptions To Genomics & Computational Drug Discovery", from the 43rd Annual Cowen Health Care Conference. The conference will be held March 6-8, 2023.
ZacksNanoString Technologies (NSTG) Reports Q4 Loss, Tops Revenue Estimates
NanoString (NSTG) delivered earnings and revenue surprises of -55.74% and 3.84%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Business WireNanoString Technologies Releases Fourth Quarter and Full Year 2022 Operating Results and Provides 2023 Financial Outlook
SEATTLE, February 28, 2023--NanoString reports Q4 and FY22 operating results.
Business WireNanoString to Webcast Presentation from the 43rd Annual Cowen Health Care Conference
SEATTLE, February 23, 2023--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 43rd Annual Cowen Health Care Conference. The conference will be held March 6-8, 2023.
Business WireNanoString to Release Fourth Quarter and Fiscal Year 2022 Operating Results and Host Conference Call on Tuesday, February 28, 2023
SEATTLE, February 14, 2023--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report fourth quarter and fiscal year 2022 operating results after the close of the market on Tuesday, February 28, 2023. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.
Business WireNanoString Showcases Ultra High-Plex 6K RNA Single Cell Imaging at the 2023 Advances in Genome Biology and Technology (AGBT)
SEATTLE, February 06, 2023--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced an update to the technology roadmap for the CosMx™ Spatial Molecular Imager (SMI) that will be presented at the 2023 Advances in Genome Biology and Technology General Meeting in Hollywood, FL. The Company is hosting the Gold Sponsor workshop on Tuesday, February 7th from 12:00-1:30pm EST. This event will also be live-streamed
Business WireWeill Cornell Medicine and NanoString Collaborate to Create Comprehensive Spatial Atlas of Human Anatomy
SEATTLE, February 02, 2023--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, announced the launch of the Spatial Atlas of Human Anatomy (SAHA) initiative, in collaboration with Weill Cornell Medicine, to create multicellular, single-cell, and sub-cellular maps of 30 non-diseased organs from a healthy and diverse population of adults.
Business WireNanoString Releases Single Cell Spatial Transcriptomics Dataset Highlighting Data Quality of CosMx Spatial Molecular Imager
SEATTLE, January 19, 2023--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a public release of new data generated by the CosMx™ Spatial Molecular Imager (SMI). This data was generated from formalin-fixed paraffin-embedded (FFPE) human liver samples and showcases the best-in-class data quality of the CosMx SMI. The dataset highlights CosMx SMI’s high sensitivity, with the capability to detect and quan
Business WireNanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2022
SEATTLE, January 08, 2023--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for the fourth quarter and fiscal year ended December 31, 2022.
Business WireNational Geographic Highlights Use of the CosMx Spatial Molecular Imager in Alzheimer’s Disease Research
SEATTLE, January 03, 2023--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s CosMx™ Spatial Molecular Imager (SMI) has been highlighted in the January edition of National Geographic Magazine. An article entitled ‘Living Longer and Better’ highlighted research from Wake Forest University, which used the CosMx SMI to study human brain tissue from patients with Alzheimer’s disease to re